Sánchez Torres G, Posadas Romero C, Tena Tamayo C, Hernández Santamaría I
Instituto Nacional de Cardiología de Mexico, Ignacio Chavez.
Drugs. 1988;35 Suppl 6:111-7. doi: 10.2165/00003495-198800356-00016.
To determine the importance of systemic arterial hypertension (SAH) in the pathogenesis of coronary atherosclerosis (CA), the coronary stenosis (CSI), coronary diffuse atheromatous (CDAI) and coronary tortuosity (CTI) indices were assessed by selective coronary angiography (SCA) in 132 survivors of a definite first myocardial infarction (MI). Patients were divided into 2 groups according to the absence (group A, n = 60) or presence (group B, n = 72) of SAH. Group B was further subdivided into 2 subgroups: group B1, consisting of 62 patients receiving no antihypertensive treatment before admission, and group B2, consisting of 20 patients treated continuously for at least 2 years with a diuretic or diuretic + beta-blocker. There were no differences in age, topography of MI, serum total cholesterol and triglyceride concentrations, prevalence of diabetes mellitus or smoking habits, CSI and CTI among the groups or subgroups of patients. Group B had a higher CTI (7.2 +/- 2.8) than Group A (2.7 +/- 2.3, p less than or equal to 0.001). None of the above indices were statistically different between subgroups B1 and B2. Surprisingly, the degree and extent of CA assessed by CSI and CDAI were similar in this population, regardless of the presence or absence of SAH and whether or not patients were treated with a diuretic. Although hypertension was related to tortuosity of the coronary arteries, which does not have a strong role in the development of CA, it is possible that the hypertensive process is relevant to the installation of atheromatous disease but not to its progression. Further studies are needed to clarify this point.
为了确定系统性动脉高血压(SAH)在冠状动脉粥样硬化(CA)发病机制中的重要性,我们通过选择性冠状动脉造影(SCA)对132例明确的首次心肌梗死(MI)幸存者的冠状动脉狭窄(CSI)、冠状动脉弥漫性动脉粥样硬化(CDAI)和冠状动脉迂曲(CTI)指数进行了评估。根据是否存在SAH将患者分为2组:A组(n = 60)无SAH,B组(n = 72)有SAH。B组进一步分为2个亚组:B1组,由62例入院前未接受抗高血压治疗的患者组成;B2组,由20例用利尿剂或利尿剂+β受体阻滞剂持续治疗至少2年的患者组成。患者组间及亚组间在年龄、心肌梗死部位、血清总胆固醇和甘油三酯浓度、糖尿病患病率或吸烟习惯、CSI和CTI方面均无差异。B组的CTI(7.2±2.8)高于A组(2.